Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...

Summit Therapeutics (SMMT) stock received a new buy rating from Truist based on its deal-forming prospects in oncology. Read ...

LVMH's undervalued stock presents a buying opportunity with strong long-term growth potential. Click here to read an analysis ...

Q2 2025 Earnings Conference Call January 8, 2025 8:00 AM ETCompany ParticipantsJim Clemmer - President and Chief ...

Bitcoin's price projected to range between $70,000 and $150,000 in 2025 amidst market volatility and geopolitical shifts. Explore more details here.

Jefferies upgrades GE Healthcare to buy, citing growth potential in imaging, patient care, and pharmaceutical diagnostics. Read more here.

PayPal's current valuation suggests a 23% upside, supported by technical analysis and potential EPS outperformance. Learn ...

Grayscale Bitcoin Mini Trust ETF stands out with a 0.15% expense ratio. Read why BTC could reach $200,000 by late 2025 as adoption increases.

Fagron (ARSUF) has refocused its M&A strategy, regaining market trust despite recent FDA issues. Read why I think the stock ...

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

Q1 2025 Earnings Conference Call January 8, 2025 8:00 AM ETCompany ParticipantsCharlotte McLaughlin - VP, IRNeil Ashe ...

GSK (GSK) stock is in focus as the company is nearing a $1B deal to acquire IDRx, a private biotech focused on a rare ...